A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Clinical trial NCT07760519 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07760519
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2026-09-30
Primary completion: 2030-04-30
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.